Nomura Research Institute (NRILY)
(Delayed Data from OTC)
$28.44 USD
+0.69 (2.49%)
Updated Mar 27, 2024 03:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Income Statements
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | 3/31/19 | |
---|---|---|---|---|---|
Sales | 5,122 | 5,444 | 4,971 | 4,861 | 4,516 |
Cost Of Goods | 3,347 | 3,521 | 3,293 | 3,198 | 3,032 |
Gross Profit | 1,775 | 1,923 | 1,678 | 1,662 | 1,484 |
Selling & Adminstrative & Depr. & Amort Expenses | 974 | 1,010 | 889 | 898 | 840 |
Income After Depreciation & Amortization | 801 | 913 | 790 | 764 | 644 |
Non-Operating Income | 43 | 50 | -44 | 181 | 52 |
Interest Expense | 41 | 31 | 104 | 4 | 4 |
Pretax Income | 803 | 932 | 642 | 942 | 691 |
Income Taxes | 237 | 293 | 167 | 297 | 227 |
Minority Interest | 1 | 3 | -3 | 9 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 566 | 639 | 475 | 645 | 464 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 565 | 636 | 478 | 637 | 464 |
Depreciation Footnote | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | 3/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,135 | 1,286 | 1,159 | 1,044 | 918 |
Depreciation & Amortization (Cash Flow) | 334 | 373 | 370 | 280 | 274 |
Income After Depreciation & Amortization | 801 | 913 | 790 | 764 | 644 |
Earnings Per Share Data | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | 3/31/19 |
---|---|---|---|---|---|
Average Shares | 591.89 | 593.69 | 598.44 | 635.15 | 707.98 |
Diluted EPS Before Non-Recurring Items | 0.95 | 1.07 | 1.07 | 1.00 | 0.65 |
Diluted Net EPS (GAAP) | 0.95 | 1.07 | 0.80 | 4.11 | 0.66 |
Fiscal Year end for Nomura Research Institute falls in the month of March .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 1,272.82 | 1,282.85 | 1,289.98 | 1,331.71 | 1,254.97 |
Cost Of Goods | NA | NA | 828.83 | NA | NA |
Gross Profit | NA | NA | 461.15 | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 258.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 203.15 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | 1.68 | NA | NA |
Interest Expense | NA | NA | 10.80 | NA | NA |
Pretax Income | NA | NA | 194.03 | NA | NA |
Income Taxes | NA | NA | 67.79 | NA | NA |
Minority Interest | NA | NA | 0.61 | NA | NA |
Investment Gains/Losses | NA | NA | 0.00 | NA | NA |
Other Income/Charges | NA | NA | 0.00 | NA | NA |
Income From Cont. Operations | 158.68 | 141.55 | 126.25 | 160.87 | 135.96 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 158.68 | 141.55 | 125.64 | 160.87 | 135.96 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 578.12 | 584.68 | 590.40 | 593.75 | 592.22 |
Diluted EPS Before Non-Recurring Items | 0.27 | 0.24 | 0.21 | 0.27 | 0.23 |
Diluted Net EPS (GAAP) | 0.27 | 0.24 | 0.21 | 0.27 | 0.23 |